维普中文期刊产品整合服务
35篇 您的检索式:作者名="Rahmutula"
    题名 作者 年代 出处 被引量
1Clinical features and prognosis in colorectal cancer patients with different ethnicities in Northwest China显示文摘AIM:To compare the clinical factors and tumor characteristics that predict survival in colorectal cancer(CRC)patients with different ethnicities in Xin Jiang area.METHODS:A total of 1421 histopathologically confirmed sporadic CRC patients who were either Han/Chinese or Uyghur were identified and enrolled from a database of both diagnoses and operative procedures from Xin Jiang Tumor Hospital,which is affiliated to Xin Jiang Medical University between 2000 and 2007.Patients with family histories of CRC,hereditary nonpolyposis CRC,familial adenomatous polyposis,inflammatory bowel disease,carcinoid,squamous carcinoma or melanoma were excluded.The two ethnic groups were compared with regard to clinical features,tumor characteristics,disease stage,overall survival rate,diseasefree survival rate and cancer-specific survival rate.The factors predicting long-term survival were assessed via both univariate and multivariate analysis.RESULTS:Among the 1421 patients with CRC enrolled in this study,1210 patients were Han/Chinese(mean age,62.3±4.5 years;range,19-92 years),while 211patients were Uyghur(mean age,52.4±15.6 years;range,17-87 years).There were significant differences in proportions of gender,age,blood type,occupation and histopathological type between the Han/Chinese and Uyghur patients(P<0.05).The median overall,disease-free and cancer-specific survival time were 45,62and 65 mo for the Han/Chinese patients and 42,49 and61 mo for the Uyghur patients(P=0.000,P=0.005,P=0.007).The cumulative 5-year survival of the Uyghur patients was significantly worse than that of the Han patients(P=0.000).A multivariate analysis showed that age,ethnicity,histopathological type,differentiation,T(Infiltration depth),N(Lymph node metastasis),staging,postoperative metastasis and metastatic site(P<0.05)were found to be the prognostic factors.CONCLUSION:The Uyghur CRC patients are associated with significantly younger age,more aggressive histopathologic characteristics and have significantly worse prognosis than the Han/Chinese patients.Akram Yusup Hai-Jiang Wang Azmat Rahmutula Parhat Sayim Ze-Liang Zhao Guo-Qing Zhang 2013World Journal of Gastroenterology2013,19,41:14
2Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1显示文摘Dolkun Rahmutula Gregory M. Marcus Emily E. Wilson Chun-Hua Ding Yuanyuan Xiao Agnes C. Paquet Rebecca Barbeau Andrea J. Barczak David J. Erle Jeffrey E. Olgin 2013Cardiovascular Research2013,,4:2
3Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure 显示文摘Lee KW Everett TH Rahmutula D 2006Circulation2006,114,16:1
4Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure显示文摘Lee KW Everett TH 4th Rahmutula D 2006Circulation2006,114,:1
5Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure 显示文摘Lee KW Everett TH Rahmutula D 2006Circulation2006,114,:1
6Systematic screening of type B human natriuretic peptide receptor gene polymor- phisms and association with essential hypertension显示文摘Rahmutula D Nakayama T Soma M 2001J HumHypertens2001,15,7:1
7Tumor necrosis factor alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelail cells显示文摘Anderson HD Rahmutula D Gardner DG 2004J Biol Chem2004,279,2:1
8Pirfenidone pre- vents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failme 显示文摘Lee KW Everett TH 4th Rahmutula D 2006Circulation2006,114,16:1
9Pirfenidone prevents the de-velopment of a vulnerable substrate for atrial fibrillation in a caninemodel ofheart failure显示文摘Lee KW Everett TH Rahmutula D 2006Circulation2006,114,:1
10Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure显示文摘Ken W. Lee Thomas H. Everett Dulkon Rahmutula Jose M. Guerra Emily Wilson Chunhua Ding Jeffrey E. Olgin 2006Circulation2006,,:1
11Isolation of the 5'-flanking region of genes by thermal asymmetric interlaced pelymerase chain reaction显示文摘Nakayama T Soma M Rahmutula D 2001Med Sei Moult2001,7,3:1
12Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1显示文摘Rahmutula D Marcus G M Wilson E E 2013Cardiovasc Res2013,99,4:1
13Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure显示文摘Lee KW Everett TH Rahmutula D 2006Circulation2006,114,:1
14Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1显示文摘Dolkun Rahmutula Gregory M. Marcus Emily E. Wilson Chun-Hua Ding Yuanyuan Xiao Agnes C. Paquet Rebecca Barbeau Andrea J. Barczak David J. Erle Jeffrey E. Olgin 2013Cardiovascular Research2013,,4:1
15Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a ca- nine model of heart failure 显示文摘Lee K W Everett T H 4th Rahmutula D 2006Circulation2006,114,16:1
16Association study between a novel single nucleotide polymorphism of the promoter region of the prostacyclin synthase gene and essential hypertension显示文摘Nakayama T Soma M Rahmutula D 2002Hypertens Res2002,25,1:1
17Nonsense mutation of prostacyclin synthase gene in a family 显示文摘Nakayama T Soma M Rahmutula K 1997Lancet1997,349,9069:1
18Atrial natri- uretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4 de- pendent mechanism 显示文摘Glenn DJ Rahmutula D Nishimoto M 2009Cardiovasc Res2009,84,2:1
19Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism显示文摘Glenn DJ Rahmutula D Nishimoto M 2009Cardiovasc Res2009,84,2:1
20Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure显示文摘LEE K W EVERETT T 4TH RAHMUTULA D 2006Circulation2006,114,16:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费